Abstract: Solid propellant is first placed in a closed container with a solution of ter and detergent. A water slurry is then created by injecting compressed air in superheated steam into the solution to place the propellant and solution under several atmospheres of pressure and at the same time to raise the temperature of the solution to 400.degree.-600.degree. F. This results in oxidation of the propellant into such constituents as carbon dioxide, water, nitrous oxide and etc. These constituents are then removed by absorption.
Type:
Grant
Filed:
April 21, 1978
Date of Patent:
July 19, 1988
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to various 2-acetyl- and 2-propionylpyridine thiosemicarbazones which are substituted on the 4-nitrogen atom. These compounds are useful in the treatment of gonorrhea and, in addition, many are useful either in the treatment of malaria or bacterial infection. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones.
Type:
Grant
Filed:
December 7, 1984
Date of Patent:
April 19, 1988
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Daniel L. Klayman, John P. Scovill, Joseph F. Bartosevich, Carl J. Mason, T. Scott Griffin
Abstract: This invention relates to novel 2-acetyl- and 2-propionylpyridine selenosemicarbazones. These compounds are useful as antimalarial and antileukemic agents. Also disclosed are several synthetic procedures used to prepare the selenosemicarbazones.
Abstract: The subject 8-[6-(N-heterocyclic-substituted)hexylamino]-6-methoxy lepidine erivatives have the formula: ##STR1## wherein Z represents methyl or, together with the two contiguous carbon atoms, the benzo moiety of a benzopiperazinyl derivative when Y is --N(R')--, n is an integer from 0 to 2; Y represents --O--, --S--, --S(O)--, --S(O).sub.2 --, and --N(R')--; R' represents hydrogen, alkyl, lower alkyl, R" substituted lower alkyl, cycloalkyl, aryl, sulfonyl, saturated 1,4-diazepinyl, lower alkyl N-cyanocarboximidothioate, or --C(O)R'"; R" represents at least one of hydroxy, alkoxy, aralkoxy, amino, lower alkyl substituted amino, phenyl, halogenated phenyl, or sufonyl; and R'" represents lower alkyl, alkoxy, aralkoxy, amino, lower alkyl substituted amino or aryl substituted amino; and pharmaceutically acceptable salts thereof. These derivatives afford improvement in means for the chemotherapy of leishmaniasis when administered parenterally or orally to infected animals.
Type:
Grant
Filed:
August 20, 1981
Date of Patent:
April 21, 1987
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to novel transition metal complexes of 2-acetyl- and -propionylpyridine thiosemicarbazones, their selenium analogs. These compounds are useful as antimalarial and antileukemic agents. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones and their selenium analogs.
Type:
Grant
Filed:
March 31, 1982
Date of Patent:
April 14, 1987
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
John P. Scovill, Daniel L. Klayman, Charles F. Franchino
Abstract: Preformed metal/oxidant agglomerates for enhancement of propellant burning ate are prepared from a finely divided metal (aluminum, boron, titanium, etc.), ammonium perchlorate, and a small quantity of the same binder material that goes into the manufacture of the propellant, such as, hydroxyl-terminated polybutadiene crosslinked with a polyisocyanate. Additional ingredients can be incorporated into the agglomerates to bring about further enhancement of burning rate, such as, an ammonium perchlorate decomposition accelerator triphenylbismuthine, a carboranyl burning rate enhancer, iron oxide, etc. Agglomerates are prepared in a fluorinated and/or chlorinated hydrocarbon solvent in which the agglomerate formulation ingredients are insoluble. Any remaining solvent is then evaporated under reduced pressure and the agglomerates are subsequently cured. Optimum mesh size of the agglomerates is 300-500 micrometers.
Type:
Grant
Filed:
April 17, 1979
Date of Patent:
April 7, 1987
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: A high energy, high performance, ultrahigh-burning rate composite propell results when 2-azidoethyl acrylate is copolymerized with acrylic acid and is employed as the binder system for the composite propellant. The energetic binder when used in an amount of about 4.25 weight percent of an azido-based propellant composition as compared to a ethyl acrylate binder system results in a specific impulse increase from about 264 (lb-s/lb) to about 275 (lb-s/lb), and a burning rate increase from about 13.7 ips to about 19.8 ips at 1000 psia, and a burning rate increase from about 21.6 ips to about 30.2 ips at 2000 psia. The other propellant ingredients comprise a high solids loading of ammonium perchlorate, aluminum flake and aluminum powder, a burning rate catalyst of carboranylmethyl propionate, graphite linters, the crosslinking and curing agent 4,5-epoxycyclohexylmethyl 4',5'-epoxycyclohexylcarboxylate (ERL-4221), tris-1,2,3[bis(1,2-difluoroamino)ethoxy]propane (TVOPA), and a processing aid of lecithin.
Type:
Grant
Filed:
May 21, 1980
Date of Patent:
April 7, 1987
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to the use of various 2-acetylpyridine thiosemicarbazones which are substituted on the 4-nitrogen atom in the treatment of viral infections. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones.
Type:
Grant
Filed:
March 30, 1982
Date of Patent:
June 24, 1986
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Charles Shipman, Jr., Daniel L. Klayman, Sandra H. Smith, John C. Drach
Abstract: A novel method has been developed for improved chemotherapy of animals infected with African trypanosomiasis. The method involves the concurrent administration of therapeutically effective amounts of cis-diamminedichloroplatinum (II) and bis-(diethylthiocarbamoyl)disulfide (disulfiram) or diethyl dithiocarbamate to the hydrated animal.
Type:
Grant
Filed:
April 3, 1981
Date of Patent:
July 30, 1985
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to various 2-acetyl- and 2-propionylpyridine thiosemicarbazones which are substituted on the 4-nitrogen atom. These compounds are useful in the treatment of gonorrhea and, in addition, many are useful either in the treatment of malaria or bacterial infection. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones.
Type:
Grant
Filed:
October 14, 1981
Date of Patent:
January 15, 1985
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Daniel L. Klayman, John P. Scovill, Joseph F. Bartosevich, Carl J. Mason, T. Scott Griffin
Abstract: This invention relates to molecular modification of hemoglobin by utilizan of a class of .alpha., .omega.-dialdelhydes having a chain length of 5 to 7 members and substituted with at least one negatively charged group such as a phosphate moiety. A subject .alpha., .omega.-dialdehyde can be synthesized by sodium periodate oxidation of a phosphorylated ribose such as adenosine-5'-triphosphate or 5-phosphoribosyl-1-pyrophosphate. The compounds of this invention can be advantageously used for intramolecularly crosslinking hemoglobin for resuscitative purposes.
Type:
Grant
Filed:
October 28, 1983
Date of Patent:
September 25, 1984
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to various 2-acetyl- and 2-propionylpyridine thiosemicarbazones which are substituted on the 4-nitrogen atom. These compounds are useful in the treatment of gonorrhea and, in addition, many are useful either in the treatment of malaria or bacterial infection. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones.
Type:
Grant
Filed:
October 14, 1981
Date of Patent:
May 8, 1984
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Daniel L. Klayman, John P. Scovill, Joseph F. Bartosevich, Carl J. Mason, T. Scott Griffin
Abstract: This invention relates to the preparation and use of various 2-acetyl quiine thiosemicarbazones which are substituted on the 4-nitrogen atom. These compounds are useful in the treatment of gonorrhea and, in addition, many are useful either in the treatment of malaria or bacterial infections, such as leprosy and meningitis.
Type:
Grant
Filed:
February 12, 1982
Date of Patent:
April 3, 1984
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
John P. Scovill, Daniel L. Klayman, Samuel P. Massie, Steven D. Grant, Armando Gonzalez, Norman E. Morrison, Arthur S. Dobek
Abstract: A bi-directional fibre-optic coupler providing about 70 dB to about 100 dB isolation from near end transmitter radiation in a system that transmits signals in opposite directions over a single fibre and thereby provides a low-loss coupler having operational characteristics to handle reception and transmission with sufficiently low value of crosstalk.
Type:
Grant
Filed:
August 26, 1980
Date of Patent:
December 20, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
David A. Grafton, Eric B. Hochberg, Ronald E. Purkis
Abstract: A novel treatment has been discovered for interrupting the life cycle of malaria parasite during its development in the liver of the vertebrate host. The subject invention involves a method of chemotherapy against sporozoite-induced malaria by administering an 8-aminoquinoline drug, such as primaquine, encapsulated within liposomes containing glycoconjugates, to a vertebrate host which has been infected with sporozoites of the parasites. Preferred species of glycoconjugates have a terminal glucose or galactose moiety, such as present in glycosyl ceramide, galactosyl ceramide, lactosyl ceramide, or in glycoproteins.
Type:
Grant
Filed:
March 17, 1982
Date of Patent:
November 22, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: The silver salt of metachloridine has been shown to have marked effectives against viruses, bacteria, fungi and protozoa. It is active against the organisms over a considerable concentration range in vitro, and has a noteworthy, high chemotherapeutic index when administered to animals by topical, oral or parenteral route. In addition to its effectiveness, silver metachloridine has been shown to be well tolerated at levels far above those required for therapeutic uses in animals.
Type:
Grant
Filed:
March 24, 1981
Date of Patent:
November 15, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to various 2-acetyl- and 2-propionylpyridine thioscarbazones which are substituted on the 4-nitrogen atom. These compounds are useful in the treatment of gonorrhea and, in addition, many are useful either in the treatment of malaria or bacterial infection. Also disclosed are several synthetic procedures used to prepare the thiosemicarbazones.
Type:
Grant
Filed:
October 14, 1981
Date of Patent:
August 30, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Daniel L. Klayman, John P. Scovill, Joseph F. Bartosevich, Carl J. Mason, T. Scott Griffin
Abstract: A device for bleeding motor gases through the motor pole piece or flange the rocket nozzle flange to reduce the control system weight and complexity and especially for fiber glass wound rocket motor cases.
Type:
Grant
Filed:
August 5, 1981
Date of Patent:
July 12, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: Water soluble hydrogels of alkali metal alginate and glycerine have been found to be excellent wound dressings. The gels dry to an adherent, non-toxic pliable protective film which can be removed by water-washing when desired. The gels are also compatible with medicaments and hence can serve as vehicles or carriers for medicament application to wounds as well as a protective cover.
Type:
Grant
Filed:
October 30, 1981
Date of Patent:
July 12, 1983
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Arthur D. Mason, Jr., Avery A. Johnson, Jr., Harrel L. Walker, Eleanor G. Bowler, Charles R. Ritchey